Skip to main content
C

Cabio Biotech(Wuhan) Co., Ltd. — Investor Relations & Filings

Ticker · 688089 Shanghai Stock Exchange Manufacturing
Filings indexed 750 across all filing types
Latest filing 2026-04-22 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688089

About Cabio Biotech(Wuhan) Co., Ltd.

Cabio Biotech (Wuhan) Co., Ltd. specializes in the research, development, and large-scale production of high-quality nutritional chemicals and functional ingredients through advanced fermentation and bio-manufacturing processes. The company’s core product portfolio includes Arachidonic Acid (ARA), algal oil Docosahexaenoic Acid (DHA), Sialic Acid (N-acetylneuraminic acid), and Beta-carotene. These ingredients are primarily utilized in infant formula, dietary supplements, functional foods, and personal care products. Cabio focuses on providing sustainable, bio-based solutions to global manufacturers, adhering to international quality standards and regulatory requirements. By leveraging its expertise in microbial oil synthesis and precision fermentation, the company supports the development of health-oriented products across the human and animal nutrition sectors.

Recent filings

Filing Released Lang Actions
嘉必优生物技术(武汉)股份有限公司2025年度审计委员会关于会计师事务所履行监督职责情况的报告
Audit Report / Information Classification · 1% confidence The document is not an annual or interim financial statement; rather, it is a formal report by the Board’s Audit Committee on its oversight of the external auditor’s work. It does not announce management changes, dividends, or legal actions, nor is it a proxy or earnings release. It represents standalone audit-related information, detailing the committee’s supervision of the audit firm’s procedures and performance, which aligns with the definition of Audit Report / Information (AR).
2026-04-22 Chinese
嘉必优生物技术(武汉)股份有限公司关于董事辞职的公告
Regulatory Filings
2026-03-25 Chinese
嘉必优生物技术(武汉)股份有限公司关于董事辞职的公告
Regulatory Filings
2026-03-20 Chinese
嘉必优生物技术(武汉)股份有限公司2025年度业绩快报公告
Regulatory Filings
2026-02-27 Chinese
嘉必优生物技术(武汉)股份有限公司关于第二期股份回购实施结果暨股份变动的公告
Regulatory Filings
2026-01-26 Chinese
嘉必优生物技术(武汉)股份有限公司关于第二期以集中竞价交易方式回购公司股份的进展公告
Regulatory Filings
2026-01-05 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.